Sio Gene Therapies Stock Debt To Equity
| SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Sio Gene Therapies fundamentals help investors to digest information that contributes to Sio Gene's financial success or failures. It also enables traders to predict the movement of Sio Stock. The fundamental analysis module provides a way to measure Sio Gene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sio Gene stock.
Sio |
Sio Gene Therapies Company Debt To Equity Analysis
Sio Gene's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Sio Gene Debt To Equity | 0.04 % |
Most of Sio Gene's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sio Gene Therapies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Sio Gene Therapies has a Debt To Equity of 0.045%. This is 99.92% lower than that of the Healthcare sector and 99.77% lower than that of the Biotechnology industry. The debt to equity for all United States stocks is 99.91% higher than that of the company.
Sio Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sio Gene's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sio Gene could also be used in its relative valuation, which is a method of valuing Sio Gene by comparing valuation metrics of similar companies.Sio Gene is currently under evaluation in debt to equity category among its peers.
Sio Fundamentals
| Return On Equity | -0.47 | |||
| Return On Asset | -0.24 | |||
| Current Valuation | (23.36 M) | |||
| Shares Outstanding | 73.98 M | |||
| Shares Owned By Insiders | 25.30 % | |||
| Shares Owned By Institutions | 26.82 % | |||
| Number Of Shares Shorted | 71.39 K | |||
| Price To Book | 0.54 X | |||
| EBITDA | (70.94 M) | |||
| Net Income | (71.89 M) | |||
| Cash And Equivalents | 54.77 M | |||
| Cash Per Share | 0.74 X | |||
| Total Debt | 2.36 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 6.46 X | |||
| Book Value Per Share | 0.61 X | |||
| Cash Flow From Operations | (60.35 M) | |||
| Short Ratio | 0.11 X | |||
| Earnings Per Share | (0.38) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 12 | |||
| Beta | 1.49 | |||
| Market Capitalization | 30.63 M | |||
| Total Asset | 75.08 M | |||
| Z Score | 7.2 | |||
| Net Asset | 75.08 M |
About Sio Gene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sio Gene Therapies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sio Gene Therapies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |